Description
Foundayo (generic name: orforglipron)
an FDA-approved, once-daily oral GLP-1 receptor agonist designed for chronic weight management in adults with obesity or overweight. Developed by Eli Lilly, it is the first oral GLP-1 medication that can be taken without food or water restrictions, offering a flexible, non-injection alternative to drugs like Wegovy.
Reviews
There are no reviews yet.